JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.85B |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.5B |
| 3 |
JPMorgan BetaBuilders Canada ETF
BBCA
|
+$1.21B |
| 4 |
Chevron
CVX
|
+$1.08B |
| 5 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$986M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$3.61B |
| 2 |
Occidental Petroleum
OXY
|
+$1.36B |
| 3 |
Merck
MRK
|
+$913M |
| 4 |
Visa
V
|
+$801M |
| 5 |
AT&T
T
|
+$771M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.95% |
| 2 | Technology | 12.9% |
| 3 | Financials | 12.36% |
| 4 | Healthcare | 9.31% |
| 5 | Consumer Discretionary | 8.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
PCOM
4651
DELISTED
Points.com Inc. Common Shares
PCOM
| $126K | ﹤0.01% |
10,406
-34,122
| -77% | -$416K |
2017 Q2
8 quarters
|
|
|
ALTA
4652
DELISTED
Altabancorp
ALTA
| $126K | ﹤0.01% |
4,307
-4,437
| -51% | -$127K |
2017 Q4
6 quarters
|
|
|
VVUS
4653
DELISTED
Vivus Inc
VVUS
| $126K | ﹤0.01% |
34,242
-40,126
| -54% | -$147K |
2018 Q4
2 quarters
|
|
4654
Fidelity MSCI Consumer Discretionary Index ETF
FDIS
$1.6B
| $125K | ﹤0.01% |
2,742
-1,491
| -35% | -$67.1K |
2015 Q4
14 quarters
|
|
4655
GeoPark
GPRK
$732M
| $125K | ﹤0.01% |
6,998
-1,519,266
| -100% | -$25.4M |
2016 Q2
12 quarters
|
|
4656
Indaptus Therapeutics
INDP
$334M
| $125K | ﹤0.01% |
+13
| New | +$164K |
2019 Q2
0 quarters
|
|
4657
Dawson Geophysical
DWSN
$86M
| $124K | ﹤0.01% |
51,548
-410,752
| -89% | -$1.02M |
2016 Q4
10 quarters
|
|
4658
Larimar Therapeutics
LRMR
$297M
| $124K | ﹤0.01% |
8,744
+1,243
| +17% | +$33.1K |
2018 Q2
4 quarters
|
|
4659
Direxion Daily S&P 500 Bear 3x ETF
SPXS
$318M
| $124K | ﹤0.01% |
66
+50
| +313% | +$98.8K |
2018 Q3
3 quarters
|
|
4660
Invesco DB US Dollar Index Bullish Fund
UUP
$441M
| $124K | ﹤0.01% |
4,760
-550
| -10% | -$14.4K |
2014 Q4
18 quarters
|
|
|
CVLY
4661
DELISTED
Codorus Valley Bancorp Inc
CVLY
| $124K | ﹤0.01% |
5,854
+508
| +10% | +$10.4K |
2017 Q4
6 quarters
|
|
|
PIR
4662
DELISTED
Pier 1 Imports, Inc.
PIR
| $124K | ﹤0.01% |
15,653
+14,369
| +1,119% | +$195K |
2014 Q4
18 quarters
|
|
4663
MediWound
MDWD
$174M
| $123K | ﹤0.01% |
5,139
-7,260
| -59% | -$224K |
2019 Q1
1 quarter
|
|
|
MRUS
4664
DELISTED
Merus
MRUS
| $123K | ﹤0.01% |
8,722
+3,389
| +64% | +$48.2K |
2019 Q1
1 quarter
|
|
|
PCTI
4665
DELISTED
PCTEL, Inc. Common Stock
PCTI
| $123K | ﹤0.01% |
27,498
+16,600
| +152% | +$82K |
2018 Q4
2 quarters
|
|
4666
Carter Bankshares
CARE
$708M
| $122K | ﹤0.01% |
+6,221
| New | +$121K |
2019 Q2
0 quarters
|
|
4667
GSI Technology
GSIT
$217M
| $122K | ﹤0.01% |
14,139
+4,698
| +50% | +$37.8K |
2017 Q4
6 quarters
|
|
|
MAXR
4668
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
| $122K | ﹤0.01% |
16,416
+2,593
| +19% | +$16.1K |
2018 Q2
4 quarters
|
|
4669
VanEck Rare Earth/Strategic Metals ETF
REMX
$1.83B
| $121K | ﹤0.01% |
2,713
+1,394
| +106% | +$62.7K |
2018 Q4
2 quarters
|
|
4670
Vanguard Short-Term Treasury ETF
VGSH
$34.4B
| $121K | ﹤0.01% |
1,993
+1,003
| +101% | +$60.7K |
2018 Q3
3 quarters
|
|
|
LTS
4671
DELISTED
Ladenburg Thalmann Financial Services Inc
LTS
| $121K | ﹤0.01% |
32,630
+1,390
| +4% | +$4.8K |
2017 Q3
7 quarters
|
|
|
LDL
4672
DELISTED
Lydall, Inc.
LDL
| $120K | ﹤0.01% |
6,176
+1,448
| +31% | +$31.5K |
2013 Q2
24 quarters
|
|
4673
Anterix
ATEX
$1.68B
| $119K | ﹤0.01% |
2,541
-3,654
| -59% | -$154K |
2017 Q4
6 quarters
|
|
4674
Teucrium Corn Fund
CORN
$129M
| $119K | ﹤0.01% |
7,082
-60
| -0.8% | -$953 |
2016 Q2
12 quarters
|
|
4675
WisdomTree Emerging Markets Corporate Bond Fund
EMCB
$96M
| $118K | ﹤0.01% |
1,627
+23
| +1% | +$1.65K |
2016 Q1
13 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2019 Portfolio in Review
As of Q2 2019, JP Morgan Chase held 6,226 positions worth $511B, up 4.5% from $490B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q2 2019 filing shows 458 new, 2,668 increased, 2,116 reduced and 420 closed positions. Its largest new stake was Corteva: 13,119,143 shares worth $388M. The largest sale was iShares 1-3 Year Treasury Bond ETF, an estimated $3.61B.
By sector, the portfolio is most concentrated in Miscellaneous at 28% of assets, up from 27% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q2 2019 buy was Corteva: 13,119,143 shares worth $388M.
- JP Morgan Chase added most to iShares 0-1 Year Treasury Bond ETF in Q2 2019, an estimated $3.85B increase.
- JP Morgan Chase's biggest Q2 2019 reduction was iShares 1-3 Year Treasury Bond ETF, cutting an estimated $3.61B.
- JP Morgan Chase fully exited Goldcorp Inc in Q2 2019, selling an estimated $131M.
- JP Morgan Chase's ten largest holdings make up 16% of its $511B portfolio in Q2 2019.
- JP Morgan Chase opened 458 new positions and closed 420 in Q2 2019.
- JP Morgan Chase's portfolio value rose 4.5% quarter-over-quarter to $511B.
Based on JP Morgan Chase's 13F filing for Q2 2019, filed 7 Aug 2019.